BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8568270)

  • 1. HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis.
    Lafrenie RM; Wahl LM; Epstein JS; Hewlett IK; Yamada KM; Dhawan S
    J Immunol; 1996 Feb; 156(4):1638-45. PubMed ID: 8568270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression.
    Lafrenie RM; Wahl LM; Epstein JS; Yamada KM; Dhawan S
    J Immunol; 1997 Oct; 159(8):4077-83. PubMed ID: 9378998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Tat increases the adhesion of monocytes and T-cells to the endothelium in vitro and in vivo: implications for AIDS-associated vasculopathy.
    Matzen K; Dirkx AE; oude Egbrink MG; Speth C; Götte M; Ascherl G; Grimm T; Griffioen AW; Stürzl M
    Virus Res; 2004 Sep; 104(2):145-55. PubMed ID: 15246652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes.
    Weiss JM; Nath A; Major EO; Berman JW
    J Immunol; 1999 Sep; 163(5):2953-9. PubMed ID: 10453044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 infection alters monocyte interactions with human microvascular endothelial cells.
    Dhawan S; Weeks BS; Soderland C; Schnaper HW; Toro LA; Asthana SP; Hewlett IK; Stetler-Stevenson WG; Yamada SS; Yamada KM
    J Immunol; 1995 Jan; 154(1):422-32. PubMed ID: 7527819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes.
    Lafrenie RM; Wahl LM; Epstein JS; Hewlett IK; Yamada KM; Dhawan S
    J Immunol; 1996 Aug; 157(3):974-7. PubMed ID: 8757599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen-mediated protection against HIV Tat protein-induced inflammatory pathways in human vascular endothelial cells.
    Lee YW; Eum SY; Nath A; Toborek M
    Cardiovasc Res; 2004 Jul; 63(1):139-48. PubMed ID: 15194470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain.
    Nottet HS; Persidsky Y; Sasseville VG; Nukuna AN; Bock P; Zhai QH; Sharer LR; McComb RD; Swindells S; Soderland C; Gendelman HE
    J Immunol; 1996 Feb; 156(3):1284-95. PubMed ID: 8558009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Tat dysregulation of lipopolysaccharide-induced cytokine responses: microbial interactions in HIV infection.
    Yim HC; Li JC; Lau JS; Lau AS
    AIDS; 2009 Jul; 23(12):1473-84. PubMed ID: 19622906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-gamma induces endothelial cells to proliferate and to invade the extracellular matrix in response to the HIV-1 Tat protein: implications for AIDS-Kaposi's sarcoma pathogenesis.
    Fiorelli V; Barillari G; Toschi E; Sgadari C; Monini P; Stürzl M; Ensoli B
    J Immunol; 1999 Jan; 162(2):1165-70. PubMed ID: 9916748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nox2-based NADPH oxidase mediates HIV-1 Tat-induced up-regulation of VCAM-1/ICAM-1 and subsequent monocyte adhesion in human astrocytes.
    Song HY; Ju SM; Seo WY; Goh AR; Lee JK; Bae YS; Choi SY; Park J
    Free Radic Biol Med; 2011 Mar; 50(5):576-84. PubMed ID: 21172429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection.
    Fanales-Belasio E; Moretti S; Fiorelli V; Tripiciano A; Pavone Cossut MR; Scoglio A; Collacchi B; Nappi F; Macchia I; Bellino S; Francavilla V; Caputo A; Barillari G; Magnani M; Laguardia ME; Cafaro A; Titti F; Monini P; Ensoli F; Ensoli B
    J Immunol; 2009 Mar; 182(5):2888-97. PubMed ID: 19234184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil alpha-defensin human neutrophil peptide modulates cytokine production in human monocytes and adhesion molecule expression in endothelial cells.
    Chaly YV; Paleolog EM; Kolesnikova TS; Tikhonov II; Petratchenko EV; Voitenok NN
    Eur Cytokine Netw; 2000 Jun; 11(2):257-66. PubMed ID: 10903805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine receptors control HIV-1 Tat-induced inflammatory responses through protein phosphatase.
    Fotheringham J; Mayne M; Holden C; Nath A; Geiger JD
    Virology; 2004 Oct; 327(2):186-95. PubMed ID: 15351206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
    Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A
    Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of human immunodeficiency virus type I tat results in down-regulation of bcl-2 and induction of apoptosis in hematopoietic cells.
    Sastry KJ; Marin MC; Nehete PN; McConnell K; el-Naggar AK; McDonnell TJ
    Oncogene; 1996 Aug; 13(3):487-93. PubMed ID: 8760290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-protein-mediated alterations in T cell interactions with the extracellular matrix proteins and endothelium.
    Mrowiec T; Melchar C; Górski A
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):255-9. PubMed ID: 9597096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus type 1 induces cellular polarization, intercellular adhesion molecule-1 redistribution, and multinucleated giant cell generation in human primary monocytes but not in monocyte-derived macrophages.
    Fais S; Borghi P; Gherardi G; Logozzi M; Belardelli F; Gessani S
    Lab Invest; 1996 Dec; 75(6):783-90. PubMed ID: 8973473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1.
    Aoudjit F; Potworowski EF; St-Pierre Y
    J Immunol; 1998 Mar; 160(6):2967-73. PubMed ID: 9510201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.